Bull/Bear Index 47.4/100
→
Daewoong Pharmaceutical's target stock price raised to 220,000 won due to surge in Nabota sales in Q2
Key takeaway
"Daewoong Pharmaceutical's target stock price raised to 220,000 won due to surge in Nabota sales in Q2" — BullBear's AI rates this story as a bullish (positive) signal for markets, with a market-impact score of 45 out of 100. Reported by TokenPost on July 03, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Catch the next bull catalyst
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 48.6%.
Join Telegram channel
or scan with phone →
